Glaxosmithkline Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 180.00 Cr
- Paid Up Capital ₹ 169.41 Cr
- Company Age 100 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.87 Cr
- Satisfied Charges ₹ 130.00 Cr
- Revenue Growth 6.42%
- Profit Growth -3.79%
- Ebitda 12.66%
- Net Worth 1.77%
- Total Assets 6.61%
About Glaxosmithkline Pharmaceuticals
Glaxosmithkline Pharmaceuticals Limited (GPL) was founded in India on 13 November 1924 and has a glorious history of 100 years and four months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500660 and on the National Stock Exchange(NSE) under GLAXO.
The Corporate was formerly known as British Drug Houses (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 180.00 Cr and a paid-up capital of Rs 169.41 Cr.
The company currently has active open charges totaling ₹21.87 Cr. The company has closed loans amounting to ₹130.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Glaxosmithkline Pharmaceuticals Limited India are Ajay Nadkarni as COMPANY SECRETARY and Juby Chandy as Cfo. Juby Chandy, Bhushan Akshikar, Subesh Williams, and Five other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
Pharma
Who are the key members and board of directors at Glaxosmithkline Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhushan Akshikar  | Managing Director | 01-Dec-2022 | Current |
| Ajay Nadkarni | Company Secretary | 01-Nov-2001 | Current |
| Juby Chandy | CFO | 01-Apr-2022 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunitha Maheshwari | Director | 18-May-2020 | Current |
| Sundaram Damodarannair | Director | 27-Jul-2009 | Current |
Subesh Williams  | Director | 07-Apr-2017 | Current |
| Renu Karnad | Director | 01-Apr-2019 | Current |
| Manu Anand | Director | 16-May-2022 | Current |
| Anami Roy | Director | 04-Nov-2011 | Current |
Financial Performance of Glaxosmithkline Pharmaceuticals.
Glaxosmithkline Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 6.42% increase. The company also saw a slight decrease in profitability, with a 3.79% decrease in profit. The company's net worth moved up by a moderate rise of 1.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glaxosmithkline Pharmaceuticals?
In 2023, Glaxosmithkline Pharmaceuticals had a promoter holding of 75.00% and a public holding of 25.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
A-Kal Televerse Private LimitedSunitha Maheshwari is a mutual person
Siemens LimitedAnami Roy is a mutual person
Schneider Electric India Private LimitedSundaram Damodarannair is a mutual person
Organisation Of Pharmaceutical Producers Of IndiaBhushan Akshikar is a mutual person
Hdfc Bank LimitedSunitha Maheshwari and Renu Karnad are mutual person
Biddle Sawyer LimitedJuby Chandy and Bhushan Akshikar are mutual person
Charges (Loans)
Open Charges
₹21.87 Cr
Satisfied Charges
₹130.00 Cr
Charges Breakdown by Lending Institutions
- The Hongkong And Shanghai Banking Corporation Ltd. : 21.87 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jul 1989 | The Hongkong And Shanghai Banking Corporation Ltd. | ₹21.87 Cr | Open |
| 20 Sep 2004 | Uti Bank Ltd. | ₹130.00 Cr | Satisfied |
How Many Employees Work at Glaxosmithkline Pharmaceuticals?
Glaxosmithkline Pharmaceuticals has a workforce of 505 employees as of Dec 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Glaxosmithkline Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Glaxosmithkline Pharmaceuticals Limited last Annual general meeting of members was held on 28 Jun 2024 as per latest MCA records.
- Balance Sheet
Glaxosmithkline Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Bhushan Arun Akshikar was appointed as a Managing Director was appointed as a Managing Director on 01 Dec 2022 & has been associated with this company since 2 years 3 months .
- Director Appointment
Manu Anand was appointed as a Director was appointed as a Director on 16 May 2022 & has been associated with this company since 2 years 10 months .
- Director Appointment
Juby Chandy was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 01 Apr 2022 & has been associated with this company since 2 years 11 months .
- Director Appointment
Juby Chandy was appointed as a Cfo was appointed as a Cfo on 01 Apr 2022 & has been associated with this company since 2 years 11 months .
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Glaxosmithkline Pharmaceuticals Limited?
Glaxosmithkline Pharmaceuticals Limited was incorporated on 13 Nov 1924.
What is authorized share capital and paid-up capital of Glaxosmithkline Pharmaceuticals Limited?
The authorized share capital of Glaxosmithkline Pharmaceuticals Limited is ₹ 180.00 Cr and paid-up capital is ₹ 169.41 Cr.
Who are the current board members & directors of Glaxosmithkline Pharmaceuticals Limited?
Currently 10 directors are associated with Glaxosmithkline Pharmaceuticals Limited.
- Juby Chandy
- Bhushan Arun Akshikar
- Subesh Ronald Williams
- Sunitha Maheshwari
- Anami Narayan Prema Roy
- Manu Anand
- Sundaram Damodarannair
- Renu Sud Karnad
- Ajay Avinash Nadkarni
- Juby Chandy
What is the registered address of Glaxosmithkline Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Glaxosmithkline Pharmaceuticals Limited is Gsk House, Dr Annie Besant Road Worli India, Mumbai, Maharashtra, 400030.
What is the corporate identification number (CIN) and company number of Glaxosmithkline Pharmaceuticals Limited?
The corporate identification number (CIN) of Glaxosmithkline Pharmaceuticals Limited is L24239MH1924PLC001151 and the company number is 001151 as per Ministry of Corporate Affairs (MCA).
Is Glaxosmithkline Pharmaceuticals Limited registered with any stock exchange in India?
Yes, Glaxosmithkline Pharmaceuticals Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): GLAXO.
What is the official website of Glaxosmithkline Pharmaceuticals Limited?
The Official website of Glaxosmithkline Pharmaceuticals Limited is https://www.india-pharma.gsk.com
What has been the recent revenue trend for Glaxosmithkline Pharmaceuticals Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Glaxosmithkline Pharmaceuticals Limited has risen by 6.42%.
How many employees does Glaxosmithkline Pharmaceuticals Limited currently have?
As Per 2024 financial reports, 505 employees are currently employed by Glaxosmithkline Pharmaceuticals Limited.
What change has been observed in the net worth of Glaxosmithkline Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Glaxosmithkline Pharmaceuticals Limited has experienced an upsurge of 1.77%.
What are the total open charges for Glaxosmithkline Pharmaceuticals Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Glaxosmithkline Pharmaceuticals Limited amount to ₹ 21.87 Cr.
When was the last Balance Sheet of Glaxosmithkline Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Glaxosmithkline Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Sridhar VenkateshManaging Director
Raju KrishnaswamyWholetime Director
Puja ThakurWholetime Director and Cfo(Kmp)
Pradeep BhideDirector
Nihal KaviratneDirector
Anjali BansalDirector
Antrinkos AristidouWholetime DirectorDP
Deepak ParekhDirector